The Key Atopic Dermatitis Companies in the market include – Kymab, BiomX, LEO Pharma, GlaxoSmithKline, Arjil Pharmaceuticals, SCM Lifescience, Sun Pharmaceutical Industries Limited, Brickell Biotech Inc,, AstraZeneca, Kyowa Kirin, UCB Biopharma, Arcutis Biotherapeutics, Vanda Pharmaceuticals, Kyowa Kirin, Sanofi, KeyMed Biosciences, Asana BioSciences, Bristol-Myers Squibb, RAPT Therapeutics, Allakos, Novartis, BioMimetix, Shanghai Hengrui Pharmaceutical Co, Connect Biopharma, […]
DelveInsight’s, “Hepatitis B Virus Infection Pipeline Insight 2024” report provides comprehensive insights about 80+ companies and 90+ pipeline drugs in Hepatitis B Virus (HBV) Infection pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the […]
Myocardial Infarction Market Myocardial Infarction Companies are Thrombologic ApS, Honya Medical Inc, Boehringer Ingelheim, KU Leuven, Pfizer, Mesoblast, Inc., Beijing Anzhen Hospital, TargeGen, GlaxoSmithKline, Stiftung Institut fuer Herzinfarktforschung, Novartis, Mitsubishi Tanabe Pharma Corporation, Bayer, KAI Pharmaceuticals, Rambam Health Care Campus, Quantum Genomics SA, Hoffmann-La Roche, Egetis Therapeutics, Stempeutics Research Pvt Ltd, Lantheus Medical Imaging, and […]
MAIKONG, a renowned manufacturer of Colonic Machine, Colon Hydrotherapy Machine, and Colonic Cleansing Machine, has been providing innovative and reliable products for over 20 years. With a focus on research, development, and production, MAIKONG has become a trusted name in the industry, offering OEM and ODM services to distributors worldwide. As a leading manufacturer, MAIKONG has a strong […]
Triple-Negative Breast Cancer Market The triple-negative breast cancer market dynamics are expected to change in the coming years with the upcoming availability of new treatment options and increasing healthcare spending across the 7MM, the treatment scenario is expected to experience significant growth during the forecast period (2024–2034). DelveInsight’s Triple-Negative Breast Cancer Market Insights report includes […]
Cholangiocarcinoma Clinical Trials As per DelveInsight’s assessment, globally, Cholangiocarcinoma pipeline constitutes 55+ key companies continuously working towards developing 60+ Cholangiocarcinoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments. (Albany, USA) “Cholangiocarcinoma Pipeline Insight 2024“ report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth […]
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Frontotemporal Dementia pipeline constitutes 15+ key companies continuously working towards developing 20+ Frontotemporal Dementia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. “Frontotemporal Dementia Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights into the […]
The Key Polymyositis Companies in the market include – Argenx, Immunoforge Co. Ltd., Chester Oddis, Kezar Life Sciences, Inc., Mallinckrodt, Merck KGaA, Astellas Pharma Inc, Genentech, Pfizer, Bristol-Myers Squibb, and others. DelveInsight’s “Polymyositis Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Polymyositis, historical and forecasted epidemiology as well as […]
DelveInsight’s, “ALK-positive Non-Small Cell Lung Cancer (ALK+ NSCLC) Pipeline Insight, 2024,” report provides comprehensive insights about 6+ companies and 7+ pipeline drugs in ALK-positive Non-Small Cell Lung Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It […]
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Exosomes pipeline constitutes 70+ key companies continuously working towards developing 75+ Exosomes treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. “Exosomes Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights into the present clinical development […]
